Net profit of Bayer CropScience declined 30.78% to Rs 93.10 crore in the quarter ended December 2023 as against Rs 134.50 crore during the previous quarter ended December 2022. Sales declined 8.00% to Rs 954.90 crore in the quarter ended December 2023 as against Rs 1037.90 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales954.901037.90 -8 OPM %13.398.23 - PBDT139.4097.20 43 PBT124.2082.90 50 NP93.10134.50 -31 Powered by Capital Market - Live News

The Board of Bayer CropScience at its meeting held on 01 February 2024 has approved the following change in directorate:Resignation of Dr. Harsh Kumar Bhanwala (DIN: 06417704) as the Non Executive Independent Director of the Company with effect from 01 February 2024. Resignation of Brian Naber, Non Executive Non-Independent Director (DIN: 09115300) with effect from 01 February 2024. Appointment of Dr. Miriam Holstein (DIN: 10458293) as Additional Non Executive Non-Independent Director with effect from 01 February 2024. Powered by Capital Market - Live News

Bayer CropScience will hold a meeting of the Board of Directors of the Company on 1 February 2024.Powered by Capital Market - Live News

Bayer CropScience announced that the Board of Directors of the Company at its meeting held on 3 November 2023, has recommended a Interim dividend of Rs.105 per share (i.e.1050%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Bayer CropScience rose 37.08% to Rs 222.90 crore in the quarter ended September 2023 as against Rs 162.60 crore during the previous quarter ended September 2022. Sales rose 11.39% to Rs 1617.20 crore in the quarter ended September 2023 as against Rs 1451.90 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales1617.201451.90 11 OPM %18.8516.39 - PBDT317.30244.20 30 PBT305.70229.00 33 NP222.90162.60 37 Powered by Capital Market - Live News